Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT00262795

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hanuschkrankenhaus Vienna, Austria
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Zentralklinikum Augsburg Augsburg, Germany
View all 88 locations
View Trial Details
Completed

Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia

NCT00276848

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Internistische Praxis - Arnstadt Arnstadt, Germany
View all 135 locations
View Trial Details
Completed

Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia

NCT00274989

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Internistische Praxis - Arnstadt Arnstadt, Germany
  • Klinikum Augsburg Augsburg, Germany
  • HELIOS Klinikum Bad Saarow Bad Saarow, Germany
  • Internistische Gemeinschaftspraxis - Berlin Berlin, Germany
View all 58 locations
View Trial Details
Completed

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

NCT01180049

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mercy Research Institute Miami, Florida, United States
  • Veterans Affairs New Jersey Healthcare System-Hematology/Oncology Section (111) East Orange, New Jersey, United States
  • Mercy Clinic Oklahoma Communities dba Mercy Clinic Oncology/Hematology-McAuley Oklahoma City, Oklahoma, United States
  • Mercy Hospital Oklahoma City-Oncology Infusion Oklahoma City, Oklahoma, United States
View all 31 locations
View Trial Details
Completed

Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

NCT02665650

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 18 locations
View Trial Details
Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

NCT00987493

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • St. Claraspital AG Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View all 16 locations
View Trial Details
Completed

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

NCT00227695

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Clinical Center - Institute of Hematology São Paulo, Brazil
  • Istituto Europeo di Oncologia IEO Milan, Italy
  • Clinical Center Skopje Skopje, North Macedonia
  • Clinical Center of Serbia Belgrade, Serbia
View all 26 locations
View Trial Details

Related conditions